ClinicalTrials.Veeva

Menu

The EASE Study - Human Factor and Usability Testing of a Binocular OCT System

University College London (UCL) logo

University College London (UCL)

Status

Completed

Conditions

Healthy Volunteers
Strabismus
Glaucoma
Retinal Disease

Treatments

Device: Binocular OCT prototype

Study type

Observational

Funder types

Other

Identifiers

NCT02822612
15/LO/1756

Details and patient eligibility

About

Ophthalmology is among the most technology driven of all medical specialties, with advanced medical imaging devices - and specialised computer software - increasingly adopted for routine clinical use. While many such devices are capable of completing specific tasks, lack of "usability" prevents their widespread adoption (i.e., such devices are not easy to learn and remember, or are not efficient or subjectively pleasing to use). Moreover, devices that are difficult to use expose patients to clinical risk as a result of human error during usage.

With the introduction of a new medical technology, it is essential, therefore, to have a deep understanding of patients, what they need, what they value, their abilities, and also their limitations.

Human factor and usability testing, also known as "human factor engineering", deals with the formal study of people's interaction with their environment (in this case, the binocular optical coherence tomography (OCT) device). Structured, patient-centred, usability testing is essential to the design, clinical validation, regulatory approval, and widespread implementation, of all new medical devices. This is particularly the case for a putative binocular OCT system - a device intended for automated use in visually impaired, often elderly, populations. Although the binocular OCT is already at an advanced stage of hardware development, the EASE study will facilitate an iterative process of operating software and workflow modifications to optimize the device for use in these populations.

Enrollment

60 patients

Sex

All

Ages

18 to 100 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria for participants with chronic eye disease will include:

  • Presence of retinal disease, glaucoma or strabismus
  • Male or female, aged 18 years or older
  • Ability to understand nature/purpose of the study and to provide informed consent
  • Ability to undergo binocular OCT imaging
  • Ability to follow instructions and complete the study
  • Ability to speak English

Exclusion criteria for participants with chronic eye disease will include:

  • Optical media opacity sufficient to preclude adequate ocular imaging with OCT
  • Hearing impairment sufficient to interfere with hearing instructions
  • Any condition which, in the investigator's opinion, would conflict or otherwise prevent the subject from complying with the required procedures, schedule, or other study conduct.

Inclusion criteria for healthy subjects will include:

  • No self-reported ocular history (although wearing corrective prescription glasses is permitted)
  • Male or female, aged 18 years or older
  • Ability to understand nature/purpose of the study and to provide informed consent
  • Ability to undergo binocular OCT imaging
  • Ability to follow instructions and complete the study
  • Ability to speak English

Exclusion criteria for healthy subjects will include:

  • Presence of ocular pathology
  • Hearing impairment sufficient to interfere with hearing instructions
  • Any condition which, in the investigator's opinion, would conflict or otherwise prevent the subject from complying with the required procedures, schedule, or other study conduct.

Trial design

60 participants in 4 patient groups

Retinal Disease
Description:
Fifteen subjects with retinal disease. Each participant will attend for a single study visit, lasting approximately 1 hour in duration.
Treatment:
Device: Binocular OCT prototype
Glaucoma
Description:
Fifteen subjects with glaucoma. Each participant will attend for a single study visit, lasting approximately 1 hour in duration.
Treatment:
Device: Binocular OCT prototype
Strabismus
Description:
Fifteen subjects with strabismus. Each participant will attend for a single study visit, lasting approximately 1 hour in duration.
Treatment:
Device: Binocular OCT prototype
Healthy volunteers
Description:
Fifteen healthy volunteers. Each participant will attend for a single study visit, lasting approximately 1 hour in duration.
Treatment:
Device: Binocular OCT prototype

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems